Assessing generalisability of cost-effectiveness estimates in multinational studies: Application to a trial of moxifloxacin in community-acquired pneumonia (CAP)

S Aballea; M Hux; S Quilici; M F Drummond

Assessing generalisability of cost-effectiveness estimates in multinational studies: Application to a trial of moxifloxacin in community-acquired pneumonia (CAP)

S Aballea, M Hux, S Quilici, M F Drummond

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	616-616
Number of pages	1
Journal	Value in Health
Volume	6
Issue number	6
Publication status	Published - 2003

Cite this

@article{b9746810d8ef434ea7f7c8768961db68,

title = "Assessing generalisability of cost-effectiveness estimates in multinational studies: Application to a trial of moxifloxacin in community-acquired pneumonia (CAP)",

author = "S Aballea and M Hux and S Quilici and Drummond, {M F}",

year = "2003",

language = "English",

volume = "6",

pages = "616--616",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "6",

}